Untitled 3

Source R&D is the authoritative source of technology and services information supporting pharmaceutical and biotechnology companies in their drug discovery and development research projects.

Source R&D features extensive listings of service providers classified under company or organisation type, including contract chemical manufacturers; contract biologics manufacturers; biological research companies and organisations; and companies and organisations providing advisory, consultancy, legal, regulatory and other services.

The extensive coverage of Source R&D and the support of life sciences organisations One Nucleus and Bionow make it an invaluable reference tool that streamlines the vendor selection process to bring pharmaceutical/biotechnology companies and suppliers together.

Polyplus-transfection introduces new nanoparticle DNA transfection reagent

Polyplus-transfection SA, a developer of innovative solutions for the delivery of nucleic acids in research, bioproduction and therapeutics, has introduced jetOPTIMUS, a new reagent for powerful nanoparticle DNA transfection. “As cell and gene therapies become more advanced and complex, this…
  • Published in Source R&D
  • Read: 9 times

Scientists develop panel of recombinant human snake venom antibodies

UK-headquartered IONTAS Limited, a company specialising in the discovery and optimisation of fully human antibodies, has published a research paper in Nature Communications in collaboration with the Technical University of Denmark and the Instituto Clodomiro Picado of the University of…
  • Published in Source R&D
  • Read: 32 times

Endomag lymphatic mapping device receives FDA approval

Surgical guidance specialist Endomag has received premarket approval from the FDA for Magtrace, the first non-radioactive, dual-tracer for lymphatic mapping in patients with breast cancer undergoing a mastectomy. Magtrace is a liquid marker designed to follow the route that cancer…
  • Published in Source R&D
  • Read: 96 times

Irvine Scientific now offers Falcon IVF products in the US

Cell culture media development and manufacturing specialist Irvine Scientific has established a new agreement with Corning Incorporated giving Irvine Scientific US distribution rights for Corning’s Falcon range of IVF dishes and plates. All Falcon IVF plasticware is manufactured from crystalline…
  • Published in Source R&D
  • Read: 110 times

Bio-Rad launches anti-ranibizumab antibodies

Bio-Rad Laboratories, Inc has launched a range of recombinant monoclonal anti-ranibizumab antibodies that are highly specific for the monoclonal antibody drug ranibizumab (Lucentis) or the complex of ranibizumab with its target, vascular endothelial growth factor A (VEGF-A). Ranibizumab is used…
  • Published in Source R&D
  • Read: 122 times

Irvine Scientific introduces chemically-defined natural killer cell expansion medium for immunotherapy and translational research applications

Cell culture media specialist Irvine Scientific has introduced PRIME-XV® NK Cell CDM as the first commercially available chemically-defined (CDM), animal component-free (ACF) medium for the ex-vivo expansion of NK cells while preserving cell potency and functionality. Current approaches to immunotherapy focus…
  • Published in Source R&D
  • Read: 156 times
Subscribe to this RSS feed